GlassScriptPhysician profile
Brooks Bahr
NPI 1831326941
$1,790.74
in general payments reported to CMS, 2019-2025
21 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $74.79 · 2021: $162 · 2022: $74.80 · 2023: $207 · 2024: $556 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.35 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $322.14 | 2023-2025 | |
| Abbvie INC. | $244.11 | 2022-2025 | Skyrizi, Botox |
| Janssen Biotech, INC. | $236.61 | 2021-2024 | Tremfya, Simponi, Stelara |
| Lilly USA, LLC | $171.95 | 2019-2025 | Taltz, Ebglyss |
| Prugen, INC. Pharmaceuticals | $138.68 | 2019-2020 | |
| Leo Pharma INC. | $130.95 | 2023-2025 | Adbry |
| Ucb, INC. | $74.28 | 2024-2025 | Bimzelx |
| Dermavant Sciences, INC. | $70.11 | 2023-2024 | Vtama |
| Vyne Pharmaceuticals INC. | $64.27 | 2021 | |
| Arcutis Biotherapeutics, INC. | $60.40 | 2023-2024 | Zoryve |
| Organon LLC | $47.16 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $33.98 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $32.57 | 2024-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $30.33 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $25.94 | 2025 | Libtayo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $25.67 | 2023 | Xeomin |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.28 | 2019 | |
| Dermira, INC. | $18.03 | 2020 | |
| Botanix Sb INC | $17.01 | 2025 | Sofdra |
| Pfizer INC. | $13.08 | 2020 | |
| Allergan, INC. | $12.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooks Bahr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.